{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:37:32Z","timestamp":1790087852612,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia","award":["Grant No. R.G.P.2\/152\/46"],"award-info":[{"award-number":["Grant No. R.G.P.2\/152\/46"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04442-y","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:45:38Z","timestamp":1752227138000},"page":"589-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiological and molecular characterisation of carbapenemase-producing Pseudomonas aeruginosa from a tertiary care hospital, India"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0999-9346","authenticated-orcid":false,"given":"Mohd Shahid","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arslan","family":"Neyaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi Kant","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"4442_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03913-6","author":"N Ahmad","year":"2025","unstructured":"Ahmad N, Siddiqui AH, Arya A et al (2025) Molecular characterization of metallo-beta-lactamase producers among carbapenem-resistant Pseudomonas aeruginosa from clinical samples in a tertiary care hospital, Lucknow. India Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-03913-6","journal-title":"India Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"4","key":"4442_CR2","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.22207\/JPAM.15.4.34","volume":"15","author":"PM Anooja","year":"2021","unstructured":"Anooja PM, John AP (2021) Antibacterial drug resistance pattern of Pseudomonas aeruginosa isolated from clinical specimens from a tertiary care centre in Central Kerala with special reference to carbapenemase detection. J Pure Appl Microbiol 15(4):2117\u20132124. https:\/\/doi.org\/10.22207\/JPAM.15.4.34","journal-title":"J Pure Appl Microbiol"},{"issue":"10","key":"4442_CR3","first-page":"822","volume":"26","author":"A Bari","year":"2016","unstructured":"Bari A, Zeeshan F, Zafar A, Ejaz H, Iftikhar A, Rathore AW (2016) Childhood acute bacterial meningitis: clinical spectrum, bacteriological profile and outcome. J Coll Physicians Surg Pak 26(10):822\u2013826","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"4442_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-020-00350-8","volume":"44","author":"AM Basha","year":"2020","unstructured":"Basha AM, El-Sherbiny GM, Mabrouk MI (2020) Phenotypic characterization of the Egyptian isolates \u201cextensively drug-resistant Pseudomonas aeruginosa\u201d and detection of their metallo \u03b2-lactamases encoding genes. Bull Natl Res Centre 44(1):1\u201311. https:\/\/doi.org\/10.1186\/s42269-020-00350-8","journal-title":"Bull Natl Res Centre"},{"key":"4442_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/asheducation-2013.1.428","volume":"2013","author":"M Bassetti","year":"2013","unstructured":"Bassetti M, Righi E (2013) Multidrug-resistant bacteria: what is the threat? Haematology Am Soc Hematol Educ Program 2013:428\u2013432. https:\/\/doi.org\/10.1182\/asheducation-2013.1.428","journal-title":"Haematology Am Soc Hematol Educ Program"},{"key":"4442_CR6","doi-asserted-by":"publisher","unstructured":"Behzadi P, Bar\u00e1th Z, Gajd\u00e1cs M (2021) It\u2019s not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiot (Basel) 10(1). https:\/\/doi.org\/10.3390\/antibacterialdrugs10010042","DOI":"10.3390\/antibacterialdrugs10010042"},{"key":"4442_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ja.2016.38","volume":"69","author":"C Bretonni\u00e8re","year":"2016","unstructured":"Bretonni\u00e8re C, Maitte A, Caillon J, Potel G, Boutoille D, Jacqueline C et al (2016) MIC score, a new tool to compare bacterial susceptibility to antibacterial drugs application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa. J Antibiot (Tokyo) 69:806\u2013810","journal-title":"J Antibiot (Tokyo)"},{"key":"4442_CR8","doi-asserted-by":"publisher","unstructured":"Cavalcanti FL, Almeida AC, Vilela MA, Morais MM, Morais Junior MA (2012) Changing the epidemiology of carbapenem resistant Pseudomonas aeruginosa in a Brazilian teaching hospital: the replacement of S\u00e3o Paulo metallo-\u03b2-lactamase-producing isolates. Mem Inst Oswaldo Cruz 107(3):420\u2013423. https:\/\/doi.org\/10.1590\/s0074-02762012000300019","DOI":"10.1590\/s0074-02762012000300019"},{"key":"4442_CR9","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2020) Performance standards for antibacterial drug susceptibility testing. 32nd ed. CLSI sup plement M100S. Pennsylvania: CLSI"},{"issue":"10","key":"4442_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s11606-013-2421-5","volume":"28","author":"B Cohen","year":"2013","unstructured":"Cohen B, Choi YJ, Hyman S, Furuya EY, Neidell M, Larson E (2013) Gender differences in risk of bloodstream and surgical site infections. J Gen Intern Med 28(10):1318\u20131325. https:\/\/doi.org\/10.1007\/s11606-013-2421-5","journal-title":"J Gen Intern Med"},{"key":"4442_CR11","unstructured":"Collee J G, Mackie T J and McCartney J E (1996) Mackie & McCartney Practical medical microbiology. New York: Churchill Livingstone, Print. 14th edition"},{"key":"4442_CR12","doi-asserted-by":"crossref","unstructured":"Dantas RC, Ferreira ML, Gontijo-Filho PP, Ribas RM (2014) Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome. J Med Microbiol 63(Pt jmm.0.073262\u20130 12):1679\u20131687. https:\/\/doi.org\/10.1099\/","DOI":"10.1099\/jmm.0.073262-0"},{"issue":"1","key":"4442_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/biomed3010006","volume":"3","author":"CI Djuikoue","year":"2023","unstructured":"Djuikoue CI, Djouela Djoulako PD, Same Njanjo HV, Kiyang CP, Djantou Biankeu FL, Guegang C, Tchouotou ASD, Wouambo RK, Thumamo Pokam BD, Apalata T, Jeannot K (2023) Phenotypic characterization and prevalence of carbapenemase-producing Pseudomonas aeruginosa isolates in six health facilities in Cameroon. BioMed 3(1):77\u201388. https:\/\/doi.org\/10.3390\/biomed3010006","journal-title":"BioMed"},{"key":"4442_CR14","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1007\/s11033-022-07930-z","volume":"49","author":"H Ejaz","year":"2022","unstructured":"Ejaz H (2022) Molecular characterization and antibiogram of the carbapenemase gene variants in clinical strains of Pseudomonas aeruginosa. Mol Biol Rep 49:10531\u201310539. https:\/\/doi.org\/10.1007\/s11033-022-07930-z","journal-title":"Mol Biol Rep"},{"key":"4442_CR15","doi-asserted-by":"publisher","unstructured":"Ejaz H, Javeed A, Zubair M (2018) Bacterial contamination of Pakistani currency notes from hospital and community sources. Pak J Med Sci 34(5):1225\u20131230. https:\/\/doi.org\/10.12669\/pjms.345.15477","DOI":"10.12669\/pjms.345.15477"},{"key":"4442_CR16","doi-asserted-by":"publisher","first-page":"26522","DOI":"10.1038\/srep26522","volume":"6","author":"X Fan","year":"2016","unstructured":"Fan X, Wu Y, Xiao M, Xu ZP, Kudinha T, Bazaj A, Kong F, Xu YC (2016) Diverse genetic background of multidrug-resistant Pseudomonas aeruginosa from Mainland China, and emergence of an extensively drug-resistant ST292 clone in Kunming. Sci Rep 6:26522. https:\/\/doi.org\/10.1038\/srep26522","journal-title":"Sci Rep"},{"key":"4442_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diagmicrobio.2011.11.011","volume":"72","author":"M Hagihara","year":"2012","unstructured":"Hagihara M, Kuti JL, Nicolau DP (2012) Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 72:258\u2013262","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4442_CR18","doi-asserted-by":"publisher","unstructured":"strid P\u00e9rez, Eva Gato, Jos\u00e9 P\u00e9rez-Llarena, Felipe Fern\u00e1ndez-Cuenca, Mar\u00eda Jos\u00e9 Gude, Marina Ovia\u00f1o, Mar\u00eda Eugenia Pach\u00f3n, Jos\u00e9 Garnacho, Ver\u00f3nica Gonz\u00e1lez, \u00c1lvaro Pascual, Jos\u00e9 Miguel Cisneros, Germ\u00e1n Bou (May 2019) High incidence of MDR and XDR\u00a0Pseudomonas aeruginosa\u00a0isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.\u00a0J Antibacterial Chemotherapy\u00a0Volume 74(Issue 5): Pages 1244\u20131252\u00a0https:\/\/doi.org\/10.1093\/jac\/dkz030","DOI":"10.1093\/jac\/dkz030"},{"key":"4442_CR19","doi-asserted-by":"publisher","unstructured":"Hilliam Y, Kaye S, Winstanley C (2020) Pseudomonas aeruginosa and microbial keratitis. J Med Microbiol 69(1):3\u201313. https:\/\/doi.org\/10.1099\/jmm.0.001110","DOI":"10.1099\/jmm.0.001110"},{"key":"4442_CR20","doi-asserted-by":"publisher","unstructured":"Hong DJ, Bae IK, Jang IH, Jeong SH, Kang HK, Lee K (2015) Epidemiology and characteristics of metallo-\u03b2-lactamase producing Pseudomonas aeruginosa. Infect Chemother 47(2):81 97. https:\/\/doi.org\/10.3947\/ic.2015.47.2.81","DOI":"10.3947\/ic.2015.47.2.81"},{"issue":"12","key":"4442_CR21","doi-asserted-by":"publisher","first-page":"823684","DOI":"10.3389\/fcimb.2022.823684","volume":"15","author":"SS Jean","year":"2022","unstructured":"Jean SS, Harnod D, Hsueh PR (2022) Global threat of carbapenem-resistant Gram-negative bacteria. Front Cell Infect Microbiol 15(12):823684. https:\/\/doi.org\/10.3389\/fcimb.2022.823684","journal-title":"Front Cell Infect Microbiol"},{"key":"4442_CR22","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1128\/JCM.39.9.3247-3253.2001","volume":"39","author":"P Joyanes","year":"2001","unstructured":"Joyanes P, del Carmen Conejo M, Mart\u00ednez-Mart\u00ednez L, Perea EJ (2001) Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting Gram-negative rods frequently isolated from clinical samples. J Clin Microbiol 39:3247\u20133253. https:\/\/doi.org\/10.1128\/JCM.39.9.3247-3253.2001","journal-title":"J Clin Microbiol"},{"key":"4442_CR23","doi-asserted-by":"publisher","unstructured":"Jurado-Mart\u00edn I, Sainz-Mej\u00edas M, McClean S (2021) Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors. Int J Mol Sci 22(6). https:\/\/doi.org\/10.3390\/ijms22063128","DOI":"10.3390\/ijms22063128"},{"issue":"12","key":"4442_CR24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3855\/jidc.1050","volume":"4","author":"F Kaleem","year":"2010","unstructured":"Kaleem F, Usman J, Hassan A, Khan A (2010) Frequency and susceptibility pattern of metallo-beta-lactamase producers in a hospital in Pakistan. J Infect Dev Ctries 4(12):810\u2013813. https:\/\/doi.org\/10.3855\/jidc.1050","journal-title":"J Infect Dev Ctries"},{"key":"4442_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12866-017-1012-8","volume":"17","author":"AU Khan","year":"2017","unstructured":"Khan AU, Maryam L, Zarrilli R (2017) Structure, genetics and worldwide spread of New Delhi metallo-\u03b2-lactamase (NDM): a threat to public health. BMC Microbiol 17:101. https:\/\/doi.org\/10.1186\/s12866-017-1012-8","journal-title":"BMC Microbiol"},{"key":"4442_CR26","doi-asserted-by":"publisher","unstructured":"Kim YJ, Jun YH, Kim YR, Park KG, Park YJ, Kang JY, Kim SI (2014) Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antibacterial therapy. BMC Infect Dis 14:161. https:\/\/doi.org\/10.1186\/1471-2334-14-161","DOI":"10.1186\/1471-2334-14-161"},{"issue":"9","key":"4442_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"KK Kumarasamy","year":"2010","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibacterial drug resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10(9):597\u2013602. https:\/\/doi.org\/10.1016\/S1473-3099(10)70143-2","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"4442_CR28","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O (2013) Antibacterial drug resistance-the need for global solutions. Lancet Infect Dis 13(12):1057\u20131098. https:\/\/doi.org\/10.1016\/S1473-3099(13)70318-9","journal-title":"Lancet Infect Dis"},{"key":"4442_CR29","doi-asserted-by":"crossref","unstructured":"Lee K, Lim YS, Yong D, Yum JH, Chong Y (2003) Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41(10):4623\u20139","DOI":"10.1128\/JCM.41.10.4623-4629.2003"},{"key":"4442_CR30","doi-asserted-by":"publisher","unstructured":"Lipsky BA, Senneville \u00c9, Abbas ZG, Arag\u00f3n-S\u00e1nchez J, Diggle M, Embil JM, Kono S, Lavery LA, Malone M, van Asten SA, Urban\u010di\u010d-Rovan V, Peters EJG (2020) International Working Group on the Diabetic Foot (IWGDF). Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF (2019) update). Diabetes Metab Res Rev 36 Suppl 1:e3280. https:\/\/doi.org\/10.1002\/dmrr.3280","DOI":"10.1002\/dmrr.3280"},{"key":"4442_CR31","doi-asserted-by":"publisher","unstructured":"Logan LK, Weinstein RA (2017) The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 215(suppl_1):S28-S36. https:\/\/doi.org\/10.1093\/infdis\/jiw282","DOI":"10.1093\/infdis\/jiw282"},{"key":"4442_CR32","doi-asserted-by":"publisher","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281.\u00a0https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"4442_CR33","doi-asserted-by":"publisher","unstructured":"Mohamed S, Ahmed Z, Mubarak, Mubarak T, Mohamed S, Mohamed R, Higazi H, Ali S (2023) Co-occurrence of carbapenemase genes blaNDM, blaVIM, blaKPC and blaOXA-48 in Pseudomonas aeruginosa clinical isolates. Int J Biomed 13:123\u2013126. https:\/\/doi.org\/10.21103\/Article13(3)_OA12","DOI":"10.21103\/Article13(3)_OA12"},{"key":"4442_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fmicb.2013.00422","volume":"4","author":"Y Morita","year":"2014","unstructured":"Morita Y, Tomida J, Kawamura Y (2014) Responses of Pseudomonas aeruginosa to antibacterials. Front Microbiol 4:422. https:\/\/doi.org\/10.3389\/fmicb.2013.00422","journal-title":"Front Microbiol"},{"key":"4442_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12348-021-00268-w","volume":"11","author":"P Naik","year":"2021","unstructured":"Naik P, Pandey S, Gagan S et al (2021) Virulence factors in multidrug (MDR) and Pan-drug resistant (XDR) Pseudomonas aeruginosa: a cross-sectional study of isolates recovered from ocular infections in a high-incidence setting in southern India. J Ophthal Inflamm Infect 11:36. https:\/\/doi.org\/10.1186\/s12348-021-00268-w","journal-title":"J Ophthal Inflamm Infect"},{"issue":"2","key":"4442_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1473-3099(14)70850-3","volume":"15","author":"RL Nation","year":"2015","unstructured":"Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD (2015) Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis 15(2):225\u2013234. https:\/\/doi.org\/10.1016\/S1473-3099(14)70850-3","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"4442_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4103\/ijccm.IJCCM_341_17","volume":"21","author":"A Negi","year":"2017","unstructured":"Negi A, Anand M, Singh A, Kumar A, Sahu C, Prasad KN (2017) Assessment of doripenem, meropenem, and imipenem against respiratory isolates of Pseudomonas aeroginosa in a tertiary care hospital of North India. Indian J Crit Care Med 21(10):703\u2013706. https:\/\/doi.org\/10.4103\/ijccm.IJCCM_341_17","journal-title":"Indian J Crit Care Med"},{"issue":"2","key":"4442_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","volume":"6","author":"P Pachori","year":"2019","unstructured":"Pachori P, Gothalwal R, Gandhi P (2019) Emergence of antibacterial drug resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis 6(2):109\u2013119. https:\/\/doi.org\/10.1016\/j.gendis.2019.04.001","journal-title":"Genes Dis"},{"issue":"1","key":"4442_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z (2019) Antibacterial drug resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37(1):177\u2013192. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.11.013","journal-title":"Biotechnol Adv"},{"issue":"11","key":"4442_CR40","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1128\/aac.00296-11","volume":"55","author":"KM Papp-Wallace","year":"2011","unstructured":"Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (2011) Carbapenems: past, present, and future. Antimicrob Agents Chemother 55(11):4943\u20134960. https:\/\/doi.org\/10.1128\/aac.00296-11","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4442_CR41","doi-asserted-by":"publisher","first-page":"e00088","DOI":"10.1128\/CMR.00088-17","volume":"31","author":"SR Partridge","year":"2018","unstructured":"Partridge SR, Kwong SM, Firth N, Jensen SO (2018) Mobile genetic elements associated with antibacterial resistance. Clin Microbiol Rev 31(4):e00088-e117. https:\/\/doi.org\/10.1128\/CMR.00088-17","journal-title":"Clin Microbiol Rev"},{"issue":"19","key":"4442_CR42","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1056\/NEJMra0904124","volume":"362","author":"AY Peleg","year":"2010","unstructured":"Peleg AY, Hooper DC (2010) Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 362(19):1804\u20131813. https:\/\/doi.org\/10.1056\/NEJMra0904124","journal-title":"N Engl J Med"},{"issue":"2","key":"4442_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00064-16","volume":"30","author":"L Poirel","year":"2017","unstructured":"Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30(2):557\u2013596. https:\/\/doi.org\/10.1128\/CMR.00064-16","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"4442_CR44","doi-asserted-by":"publisher","first-page":"e01759","DOI":"10.1128\/AAC.01759-19","volume":"64","author":"R Recio","year":"2020","unstructured":"Recio R, Manche\u00f1o M, Viedma E, Villa J, Orellana M\u00c1, Lora-Tamayo J, Chaves F (2020) Predictors of mortality in bloodstream infections caused by Pseudomonas aeruginosa and impact of antibacterial resistance and bacterial virulence. Antimicrob Agents Chemother 64(2):e01759-e1819. https:\/\/doi.org\/10.1128\/AAC.01759-19","journal-title":"Antimicrob Agents Chemother"},{"key":"4442_CR45","first-page":"20","volume":"3","author":"H Saderi","year":"2008","unstructured":"Saderi H, Karimi Z, Owlia P, Bahar MA, Rad SM (2008) Phenotypic detection of metallo-beta-lactamase producing Pseudomonas aeruginosa strains isolated from burned patients. Iran J Pathol 3:20\u201324","journal-title":"Iran J Pathol"},{"key":"4442_CR46","doi-asserted-by":"publisher","unstructured":"Jafari SA, Mehdizadeh F, Fallah G,\u00a0 Mehrdad P, Hossein BB (2024) Examining the frequency of carbapenemase genes blaKPC, blaIMP, blaOXA-48, blaSPM, blaNDM, blaVIM, blaGES, blaBIC, blaAIM, blaGIM, blaSIM, and blaDIM in Pseudomonas aeruginosa strains isolated from patients hospitalized in northwest Iran hospitals. J Experim Clin Med 41:466-473. https:\/\/doi.org\/10.52142\/omujecm.41.3.3","DOI":"10.52142\/omujecm.41.3.3"},{"key":"4442_CR47","doi-asserted-by":"publisher","unstructured":"Sheikh AF, Rostami S, Jolodar A, Tabatabaiefar MA, Khorvash F, Saki A et\u00a0al (2014) Detection of metallo-beta lactamases among carbapenem-resistant Pseudomonas aeruginosa. Jundishapur JMi crobiol 7(8). https:\/\/doi.org\/10.5812\/jjm.12289","DOI":"10.5812\/jjm.12289"},{"key":"4442_CR48","doi-asserted-by":"publisher","unstructured":"Shukla SD, Gupta G, Khatoon R, Jain R, Gupta A (2021) The rising threat of drug resistant\u00a0Pseudomonas aeruginosa- a nightmare for intensive care unit patients. J Clin of Diagn Res 15(11):DC12-DC16.\u00a0https:\/\/doi.org\/10.7860\/JCDR\/2021\/51650\/15629","DOI":"10.7860\/JCDR\/2021\/51650\/15629"},{"issue":"8","key":"4442_CR49","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3855\/jidc.9539","volume":"12","author":"A Singh-Moodley","year":"2018","unstructured":"Singh-Moodley A, Duse A, Naicker P, Kularatne R, Nana T, Lekalakala R, Mbelle N, Dawood H, Swe Swe Han K, Ramjathan P, Bhola P, Whitelaw A, Perovic O (2018) Laboratory based antimicrobial resistance surveillance for Pseudomonas aeruginosa blood isolates from South Africa. J Infect Dev Ctries 12(8):616\u2013624. https:\/\/doi.org\/10.3855\/jidc.9539","journal-title":"J Infect Dev Ctries"},{"key":"4442_CR50","doi-asserted-by":"publisher","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N (2018) WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibacterial drugs: the WHO priority list of antibacterial drug-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318\u2013327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3","DOI":"10.1016\/S1473-3099(17)30753-3"},{"issue":"4","key":"4442_CR51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/JLP.JLP_136_19","volume":"11","author":"N Verma","year":"2019","unstructured":"Verma N, Prahraj AK, Mishra B, Behera B, Gupta K (2019) Detection of carbapenemase-producing Pseudomonas aeruginosa by phenotypic and genotypic methods in a tertiary care hospital of East India. J Lab Physicians 11(4):287\u2013291. https:\/\/doi.org\/10.4103\/JLP.JLP_136_19","journal-title":"J Lab Physicians"},{"key":"4442_CR52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fmicb.2015.00595","volume":"6","author":"X Wang","year":"2015","unstructured":"Wang X, Chen G, Wu X, Wang L, Cai J, Chan EW, Chen S, Zhang R (2015) Increased prevalence of carbapenem resistant Enterobacteriaceae in hospital setting due to cross-species transmission of the blaNDM-1 element and clonal spread of progenitor resistant strains. Front Microbiol 6:595. https:\/\/doi.org\/10.3389\/fmicb.2015.00595","journal-title":"Front Microbiol"},{"key":"4442_CR53","unstructured":"WHO (2020) Global antibacterial resistance surveillance system (GLASS) report: early implementation 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/332081. Accessed 25 August 2022."},{"key":"4442_CR54","doi-asserted-by":"crossref","unstructured":"Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y (2002) Imipenem-EDTA disk method for differentiation of metallo lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 40(10):3798\u20133801.","DOI":"10.1128\/JCM.40.10.3798-3801.2002"},{"issue":"6","key":"4442_CR55","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","volume":"18","author":"MD Zilberberg","year":"2014","unstructured":"Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH (2014) Multi-drug resistance, inappropriate initial antibacterial drug therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care 18(6):596. https:\/\/doi.org\/10.1186\/s13054-014-0596-8","journal-title":"Crit Care"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04442-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:02:44Z","timestamp":1771538564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04442-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4442"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04442-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial no."}},{"value":"The study was approved by the Institutional Ethics Committee of Hind Institute of Medical Sciences (HIMS) (HIMS\/IRB\/2020\u201321\/44) and certifies that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"Written consent was taken from each participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors report no conflicts of interest in this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}